G6PD and gastric cancer: In summary, we demonstrated for the first time that Rev-erbα was recruited to promoters of PFKFB3 and G6PD genes, thereby inhibiting glycolytic flux and the PPP, and subsequent proliferation in in vitro human gastric cancer cells.